[CRBP] Corbus Pharmaceuticals Holdings, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Major Pharmaceuticals

Market Capitalization: 127.66 M

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 8.55 Change: 0.2 (2.4%)
Ext. hours: Change: 0 (0%)

chart CRBP

Refresh chart

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding43.57 M EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters Sales Growth - Q/Q P/E
P/E To EPS Growth P/S P/BV27.21 Price/Cash Per Share
Price/Free Cash Flow ROA-71.41% ROE-79.86% ROI
Current Ratio9.34 Quick Ratio Long Term Debt/Equity Debt Ratio0.12
Gross Margin Operating Margin Net Profit Margin Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities-10 K Cash From Investing Activities Cash From Operating Activities-1.28 M Gross Profit
Net Profit-1.54 M Operating Profit-1.54 M Total Assets5.25 M Total Current Assets5.18 M
Total Current Liabilities550 K Total Debt70 K Total Liabilities550 K Total Revenue
Technical Data
High 52 week9.25 Low 52 week4.65 Last close6.29 Last change1.78%
RSI32 Average true range0.42 Beta1.19 Volume250.54 K
Simple moving average 20 days-4.72% Simple moving average 50 days-7.04% Simple moving average 200 days1.91%
Performance Data
Performance Week3.8% Performance Month-8.31% Performance Quart25.8% Performance Half6.61%
Performance Year-11.41% Performance Year-to-date-11.41% Volatility daily3.78% Volatility weekly8.46%
Volatility monthly17.33% Volatility yearly60.04% Relative Volume223.98% Average Volume1.49 M
New High New Low

News

2019-03-18 09:30:01 | Is Corbus Pharmaceuticals Holdings CRBP Stock Outpacing Its Medical Peers This Year?

2019-03-17 10:03:00 | FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of DBVT, AMRN, WTW and CRBP

2019-03-15 19:56:13 | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corbus Pharmaceuticals Holdings, Inc. – CRBP

2019-03-15 11:26:53 | SHAREHOLDER ALERT: DBVT VALE SVXY CRBP: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

2019-03-15 10:35:00 | SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Announces Class Action Against Corbus Pharmaceuticals Holdings, Inc. CRBP and Lead Deadline: May 13, 2019

2019-03-15 09:30:00 | CRBP CLASS ACTION ALERT: Hagens Berman Alerts Corbus Pharmaceutical Holdings NASDAQ: CRBP Investors to May 13, 2019 Lead Plaintiff Deadline

2019-03-14 17:47:00 | Glancy Prongay & Murray LLP Announces Investigation on Behalf of Corbus Pharmaceuticals Holdings, Inc. Investors

2019-03-14 10:36:02 | Corbus Pharmaceuticals CRBP Upgraded to Strong Buy: Here's Why

2019-03-14 10:35:53 | The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MAXR, BRS, WTW and CRBP

2019-03-14 10:32:00 | SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Announces Class Action Against Corbus Pharmaceuticals Holdings, Inc. CRBP and Lead Plaintiff Deadline: May 13, 2019

2019-03-13 17:49:00 | EQUITY ALERT: Rosen Law Firm Encourages Corbus Pharmaceuticals Holdings, Inc. Investors with Over $100K in Losses to Contact the Firm – CRBP

2019-03-13 16:54:00 | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corbus Pharmaceuticals Holdings, Inc. - CRBP

2019-03-13 15:26:24 | CLASS ACTION UPDATE for SPB, ARLO, AMRN and CRBP: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

2019-03-13 15:00:00 | SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Announces Class Action Against Corbus Pharmaceuticals Holdings, Inc. CRBP and Lead Plaintiff Deadline: May 13, 2019

2019-03-13 14:38:00 | INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Corbus Pharmaceuticals Holdings, Inc. Investors

2019-03-13 12:40:05 | Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Corbus Pharmaceuticals Holdings, Inc. CRBP

2019-03-13 11:35:00 | Corbus Pharmaceuticals Holdings, Inc. CRBP Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation

2019-03-12 21:10:39 | Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Corbus Pharmaceuticals Holdings, Inc. CRBP and Encourages CRBP Investors to Contact the Firm

2019-03-12 19:11:00 | EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Corbus Pharmaceuticals Holdings, Inc. – CRBP

2019-03-12 17:18:33 | Block & Leviton LLP Announces It Has Filed A Securities Class Action Against Corbus Pharmaceuticals And Encourages Shareholders To Contact The Firm

2019-03-12 15:27:38 | Edited Transcript of CRBP earnings conference call or presentation 12-Mar-19 12:30pm GMT

2019-03-12 13:11:14 | Corbus Pharmaceuticals Holdings Inc CRBP Q4 2018 Earnings Conference Call Transcript

2019-03-12 08:25:12 | Corbus Pharmaceuticals CRBP Reports Q4 Loss, Misses Revenue Estimates

2019-03-12 07:31:44 | Corbus Pharmaceuticals: 4Q Earnings Snapshot

2019-03-12 07:00:00 | Corbus Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Clinical Updates

2019-03-11 08:35:00 | Corbus Pharmaceuticals to Present at the Oppenheimer 29th Annual Healthcare Conference

2019-03-07 08:00:00 | Corbus Pharmaceuticals to Announce Full-Year 2018 Operational and Financial Results on March 12, 2019

2019-03-05 16:06:09 | What's in the Cards for Corbus CRBP This Earnings Season?

2019-03-05 14:59:57 | ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Corbus Pharmaceuticals Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

2019-03-04 11:30:00 | INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Corbus Pharmaceuticals Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

2019-03-04 09:54:02 | Pacira PCRX Q4 Earnings and Revenues Surpass Estimates

2019-03-04 09:15:00 | Corbus Pharmaceuticals Announces Appointment of Craig Millian as Chief Commercial Officer

2019-03-01 13:36:00 | INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Corbus Pharmaceuticals Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

2019-02-28 16:54:00 | EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Corbus Pharmaceuticals Holdings, Inc. – CRBP

2019-02-28 13:49:56 | Corbus Pharmaceuticals Investigated by Block & Leviton LLP For Violations of Federal Securities Laws

2019-02-28 08:43:01 | Jazz Pharmaceuticals JAZZ Surges: Stock Moves 7.9% Higher

2019-02-27 07:13:12 | Jazz Pharma JAZZ Q4 Earnings & Sales Beat, Stock Up 8%

2019-02-21 09:15:02 | Another Round of Slight Gains Amid Choppy Session

2019-02-19 08:35:01 | Is the Options Market Predicting a Spike in Corbus Pharmaceuticals CRBP Stock?

2019-02-12 16:28:00 | Tuesday's Rally Was Driven Mostly by Technical Conditions

2019-02-12 10:43:00 | It's a Stock Picker's Delight Right Now

2019-02-11 17:50:10 | Corbus Pharmaceuticals CRBP Stock Sinks As Market Gains: What You Should Know

2019-02-07 12:01:45 | Should Corbus Pharmaceuticals Holdings, Inc. NASDAQ:CRBP Be Your Next Stock Pick?

2019-02-05 07:30:00 | Market Trends Toward New Normal in Brixmor Property Group, Navigant Consulting, Allete, Dun & Bradstreet, Corbus Pharmaceuticals, and International Seaways — Emerging Consolidated Expectations, Analyst Ratings

2019-01-31 08:00:00 | Biotech Stocks on the Rise

2019-01-30 07:30:00 | Corbus Pharmaceuticals Announces Closing of $40 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares

2019-01-29 13:24:27 | Jim Cramer Shares His Predictions For The Cannabis Industry

2019-01-25 09:01:00 | Corbus Pharmaceuticals Announces Pricing of Public Offering of Common Stock

2019-01-24 16:01:00 | Corbus Pharmaceuticals Announces Proposed Public Offering of Common Stock

2019-01-21 10:53:42 | Top Marijuana Stocks on the NASDAQ